This is true for healthy individuals and as well as for the elderly or chronically ill who may suffer from persistent low glutathione due to an impaired enzyme that is the first step responsible for making glutathione inside our cells
developed a novel DON prodrug, HDON, which can selectively activate nitroreductase in hypoxic tumor environments without affecting oxygen-rich normal tissues, showing significant tumor inhibition in the H22 mouse liver cancer model (Zheng et al., 2024)
Armstrong DG, Boulton AJM, Bus SA
What they found: Cells exposed to BPC-157 began to form capillary tubules, small prototypes of new vessels
Assuming a 50% price erosion post-generic entry and 50% market share capture by generics, the addressable opportunity could be around USD 500 million
Keeping your provider in the loop helps ensure your plan stays safe and effective